What's new

Orphan designation: imetelstat sodium Treatment of myelodysplastic syndromes, 27/07/2020 Positive

Orphan designation: imetelstat sodium Treatment of myelodysplastic syndromes, 27/07/2020 Positive

Apr 9, 2025 - 09:51
 0
Orphan designation: imetelstat sodium Treatment of myelodysplastic syndromes, 27/07/2020 Positive
Orphan designation: imetelstat sodium Treatment of myelodysplastic syndromes, 27/07/2020 Positive
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Rasagiline ratiopharm,...

Next Article

Emergency Task Force (ETF) documents

Related Posts

Human medicines European public assessment report (EPAR): Bylvay, odevixibat, Date of authorisation: 16/07/2021, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 10, 2025  0

Journey towards a roadmap for regulatory guidance on re...

Apr 3, 2025  0

Human medicines European public assessment report (EPAR): Nepexto, etanercept, Date of authorisation: 20/05/2020, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 3, 2025  0